Celldex Therapeutics, Inc. (CLDX)
NASDAQ: CLDX · Real-Time Price · USD
22.00
-0.11 (-0.50%)
Jul 3, 2025, 1:00 PM - Market closed

Celldex Therapeutics Statistics

Total Valuation

CLDX has a market cap or net worth of $1.46 billion. The enterprise value is $790.81 million.

Market Cap 1.46B
Enterprise Value 790.81M

Important Dates

The next estimated earnings date is Thursday, August 7, 2025, after market close.

Earnings Date Aug 7, 2025
Ex-Dividend Date n/a

Share Statistics

CLDX has 66.39 million shares outstanding. The number of shares has increased by 29.03% in one year.

Current Share Class 66.39M
Shares Outstanding 66.39M
Shares Change (YoY) +29.03%
Shares Change (QoQ) +0.05%
Owned by Insiders (%) 0.28%
Owned by Institutions (%) 98.02%
Float 56.36M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 192.88
Forward PS 381.48
PB Ratio 2.08
P/TBV Ratio 2.16
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 104.62
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 21.67, with a Debt / Equity ratio of 0.00.

Current Ratio 21.67
Quick Ratio 21.06
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -23.20% and return on invested capital (ROIC) is -17.55%.

Return on Equity (ROE) -23.20%
Return on Assets (ROA) -16.88%
Return on Invested Capital (ROIC) -17.55%
Return on Capital Employed (ROCE) -30.70%
Revenue Per Employee $40,640
Profits Per Employee -$961,565
Employee Count 186
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -40.56% in the last 52 weeks. The beta is 1.13, so CLDX's price volatility has been higher than the market average.

Beta (5Y) 1.13
52-Week Price Change -40.56%
50-Day Moving Average 20.29
200-Day Moving Average 23.89
Relative Strength Index (RSI) 59.25
Average Volume (20 Days) 1,237,949

Short Selling Information

The latest short interest is 7.83 million, so 11.79% of the outstanding shares have been sold short.

Short Interest 7.83M
Short Previous Month 8.37M
Short % of Shares Out 11.79%
Short % of Float 13.89%
Short Ratio (days to cover) 6.93

Income Statement

In the last 12 months, CLDX had revenue of $7.56 million and -$178.85 million in losses. Loss per share was -$2.70.

Revenue 7.56M
Gross Profit -176.94M
Operating Income -217.21M
Pretax Income -150.22M
Net Income -178.85M
EBITDA -213.94M
EBIT -217.21M
Loss Per Share -$2.70
Full Income Statement

Balance Sheet

The company has $673.29 million in cash and $3.43 million in debt, giving a net cash position of $669.86 million or $10.09 per share.

Cash & Cash Equivalents 673.29M
Total Debt 3.43M
Net Cash 669.86M
Net Cash Per Share $10.09
Equity (Book Value) 702.98M
Book Value Per Share 10.59
Working Capital 661.74M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$171.51 million and capital expenditures -$1.84 million, giving a free cash flow of -$173.35 million.

Operating Cash Flow -171.51M
Capital Expenditures -1.84M
Free Cash Flow -173.35M
FCF Per Share -$2.61
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -2,873.52%
Pretax Margin -2,366.07%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CLDX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -29.03%
Shareholder Yield -29.03%
Earnings Yield -12.24%
FCF Yield -11.87%
Dividend Details

Analyst Forecast

The average price target for CLDX is $50.00, which is 127.27% higher than the current price. The consensus rating is "Buy".

Price Target $50.00
Price Target Difference 127.27%
Analyst Consensus Buy
Analyst Count 9
Revenue Growth Forecast (5Y) 149.42%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on February 11, 2019. It was a reverse split with a ratio of 0.0666666:1.

Last Split Date Feb 11, 2019
Split Type Reverse
Split Ratio 0.0666666:1

Scores

CLDX has an Altman Z-Score of 31.21 and a Piotroski F-Score of 1.

Altman Z-Score 31.21
Piotroski F-Score 1